Azar Rezapour

2PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 14, 2023
A type I interferon footprint in pre-operative biopsies is an independent biomarker that in combination with CD8+ T cell quantification can improve the prediction of response to neoadjuvant treatment of rectal adenocarcinoma.

Azar Rezapour, Daniel Rydbeck, Fabian Byvald

|Oct 23, 2021
Antigen Presenting Cells from Tumor and Colon of Colorectal Cancer Patients Are Distinct in Activation and Functional Status, but Comparably Responsive to Activated T Cells.

Frank Liang, Azar Rezapour, Louis Szeponik

Pageof 1

Frequent Collaborators

2 joint publications

Ulf Yrlid

1 joint publications

Frank Liang

1 joint publications

Louis Szeponik

1 joint publications

Samuel Alsén